UPDATE: Feltl & Co Upgrades DexCom from Hold to Buy and Lowers PT from $15.85 to $15.35 - DexCom (NASDAQ:DXCM)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Feltl and Company has published a research report on DexCom Inc. (NASDAQ: DXCM) upgrading the company.In the report, Feltl & Company wrote, "The recent market correction has seen DexCom sell off to near its 52-week low. This has lowered the company's enterprise value to ~$650 million or about 3.8x our 2013 revenue estimate. We believe the current share price offers a favorable risk-reward trade-off, especially for a company growing at over 40% and rapidly approaching profitability."Feltl & Company upgraded DexCom from Hold to BUY with a price target lowered from $15.85 to $15.35. DexCom closed Monday at $11.54.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!